Results 1 to 10 of about 26,895 (263)

Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study. [PDF]

Medicina (Kaunas)
Mateoc T, Suciu IM, Gaiță D, Minodora A, Popescu R, Vlad T, Flangea C, Muntean C, Vlad DC.   +8 more
europepmc   +1 more source

Sex-consistent outcomes in SGLT2 inhibitor-treated acute myocardial infarction patients: a real-world study. [PDF]

Eur J Med Res
Guo C, Dou JH, Guo FS, Zhao S, Wu RY, Hu YW, Liu S, Wei J.   +7 more
europepmc   +1 more source

Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study. [PDF]

Cardiovasc Diabetol
Avidan Y, Danon A, Hadar D, Aker A, Yahav A, Caspi O, Kassem S.   +6 more
europepmc   +1 more source

Multiple Effects of SGLT2 Inhibitors

JMA Journal
openaire   +2 more sources

Emphysematous Cystitis in an Immunocompetent Patient on an SGLT2 Inhibitor. [PDF]

Cureus
Nguyen KN, Bista DR.
europepmc   +1 more source

Unmasking of SGLT2 inhibitor associated ketoacidosis after initiation of mechanical ventilation with consecutive cardiopulmonary resuscitation and extracorporeal life support: A case report. [PDF]

Eur J Anaesthesiol Intensive Care
Nienhaus J, M'Pembele R, Kindgen-Milles D, Dalyanoglu H, Roth S.   +4 more
europepmc   +1 more source

Clinical outcomes of SGLT2 inhibitor use in Thai patients with heart failure: a five-year retrospective cohort study. [PDF]

Int J Cardiol Heart Vasc
Chanchanayothin T, Klomwong C, Saisri T, Panudom S, Chaiyamahapurk S, Theerasuwipakorn N, Siranart N, Pajareya P, Songsirisuk N, Pravarnpat C, Pipatputthapong A, Jittham P, Kosum P.   +12 more
europepmc   +1 more source

SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series. [PDF]

Adv Hematol
Artz A, Nguyen T, Samoa R, Kim H, Tse W, Jin R, Goutnik S.   +6 more
europepmc   +1 more source

Changes in NT-proBNP Levels According to SGLT2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Decompensation: A Prospective Cohort Study. [PDF]

Life (Basel)
Fountoulakis PN, Theofilis P, Oikonomou E, Siasos G, Pallantza Z, Bounta M, Karakasis P, Vlachakis PK, Tsioufis K, Tousoulis D.   +9 more
europepmc   +1 more source

Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio. [PDF]

Am Heart J Plus
Nasrollahizadeh A, Javankiani S, Rahmati S, Nasrollahizadeh A, Hakim D, Modin D, Johansen ND, Biering-Sørensen T, Hosseini K.   +8 more
europepmc   +1 more source